Get Alto Neuroscience alerts:Alto Neuroscience, Inc. (NYSE:ANRO – Free Report) – Equities research analysts at Chardan Capital issued their FY2025 earnings per share (EPS) estimates for shares of Alto Neuroscience in a note issued to investors on Tuesday, September 30th. Weiss Ratings reissued a “sell (d-)” rating on shares of Alto Neuroscience in a research report on Saturday, September 27th. Alto Neuroscience Stock Up 55.8%ANRO opened at $6.87 on Friday. Alto Neuroscience (NYSE:ANRO – Get Free Report) last announced its quarterly earnings data on Wednesday, August 13th. See AlsoReceive News & Ratings for Alto Neuroscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alto Neuroscience and related companies with MarketBeat.com's FREE daily email newsletter.